Invention Grant
- Patent Title: Antagonists of IL-23P19 for treatement of atopic dermatitis
- Patent Title (中): IL-23P19拮抗剂用于治疗特应性皮炎
-
Application No.: US13762133Application Date: 2013-02-07
-
Publication No.: US08795666B2Publication Date: 2014-08-05
- Inventor: Madaline Chirica , Robert A. Kastelein , Kevin Moore , Christi L. Parham
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/00
Abstract:
Nucleic acids encoding mammalian, e.g., primate, receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.
Public/Granted literature
- US20130156729A1 Mammalian Receptor Proteins; Related Reagents and Methods Public/Granted day:2013-06-20
Information query
